Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
09/2003
09/18/2003WO2003076443A1 Spiro compounds with npy antagonistic activity
09/18/2003WO2003076438A1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076430A1 Amino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076426A2 Pyridinyloxy derivatives as 5-ht receptor ligands
09/18/2003WO2003076422A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076421A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076417A2 Oxo-azabicyclic compounds
09/18/2003WO2003076416A1 Oxo azabicyclic compounds
09/18/2003WO2003076406A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
09/18/2003WO2003076405A1 Monocyclic aroylpyridinones as antiinflammatory agents
09/18/2003WO2003076404A1 Chain oligolactic acid thioester
09/18/2003WO2003076400A1 New inhibitors of histone deacetylase
09/18/2003WO2003076397A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003WO2003076395A1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076374A1 PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE
09/18/2003WO2003075959A1 Matrix metalloproteinase inhibitors in combination with hypothermia and/or radiotherapy for the treatment of cancer
09/18/2003WO2003075929A1 Inhibitors of histone deacetylase
09/18/2003WO2003075907A2 Small molecule entry inhibitors
09/18/2003WO2003075857A2 Amino-methyl substituted tetracycline compounds
09/18/2003WO2003075847A2 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS
09/18/2003WO2003075836A2 Cathepsin cysteine protease inhibitors
09/18/2003WO2003053915A3 Compounds for the treatment of inflammatory disorders
09/18/2003WO2003053368A3 Chalcone derivatives and their use to treat diseases
09/18/2003WO2003039454A8 Beta-secretase inhibitors and methods of use
09/18/2003WO2003037308A3 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion
09/18/2003WO2003011851A3 Aromatic hydroxamic acid derivatives useful as hdac inhibitors
09/18/2003WO2002076925A3 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
09/18/2003WO2002062750A9 Cannabinoid receptor ligands
09/18/2003WO2002034745A8 Chemokine receptor binding heterocyclic compounds
09/18/2003US20030176726 Selective retinoid agonists
09/18/2003US20030176709 Vinyl-phenyl pyridine monomers and polymers prepared thereform
09/18/2003US20030176707 Process for preparing integrin antagonist intermediate
09/18/2003US20030176705 Process for the preparation of 2-chloro-5-methylpyridine-3-carbaldehyde
09/18/2003US20030176497 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
09/18/2003US20030176485 Calcium receptor active compounds
09/18/2003US20030176471 Process of preparing 3S-3-amino-3aryl propionic acid and derivatives thereof
09/18/2003US20030176469 Anthranylalkyl and cycloalkyl amides and use thereof as vegf receptor inhibitors
09/18/2003US20030176468 Reacting keto-vinyl ether compound with dialkylaminoacrylate compound to obtain dialkylamino-oxo-ester compound; reacting with ammonia or ammonium compound to form nicotinic ester compound, hydrolysis
09/18/2003US20030176439 For therapy and prophylaxis of thromboembolic diseases and restenoses; reversible inhibitors of the blood clotting enzyme factor VIIa
09/18/2003US20030176434 Compounds and methods for promoting smoking cessation
09/18/2003US20030176398 Prodrugs of GABA analogs, compositions and uses thereof
09/18/2003CA2482191A1 Spiro compounds with npy antagonistic activity
09/18/2003CA2480001A1 Chain oligolactic acid thioester
09/18/2003CA2479065A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003CA2478936A1 Monocyclic aroylpyridinones as antiinflammatory agents
09/18/2003CA2478706A1 Oxo-azabicyclic compounds
09/18/2003CA2478652A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
09/18/2003CA2478522A1 Novel curcuminoid-factor viia constructs as suppressors of tumor growth and angiogenesis
09/18/2003CA2478110A1 Novel fluorescent label compounds
09/18/2003CA2475254A1 Pyridinyloxy derivatives as 5-ht receptor ligands
09/17/2003EP1344525A1 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
09/17/2003EP1343783A2 Substituted imidazopyridines
09/17/2003EP1343775A2 Piperazine derivatives
09/17/2003EP1343764A1 Urea and urethane derivatives as integrin inhibitors
09/17/2003EP1343763A1 Pyrodone derivatives as ap2 inhibitors
09/17/2003EP1343561A1 Serine protease inhibitors
09/17/2003EP1343530A1 Oral pharmaceutical composition containing a block copolymer
09/17/2003EP1343505A1 Cxcr3 antagonists
09/17/2003EP1343503A1 Heteroaryl urea neuropeptide y y5 receptor antagonists
09/17/2003EP1343497A1 $g(D)?2 ,-1,2,3-TRIAZOLINE ANTICONVULSANTS AND THEIR ACTIVE METABOLITE ANALOGUES, THE AMINOALKYLPYRIDINES, ARE EXCITATORY AMINO ACID ANTAGONISTS AND ANTIISCHEMIC AGENTS, USEFUL IN THE TREATMENT OF CEREBRAL ISCHEMIA RESULTING FROM STROKE
09/17/2003EP1343493A2 Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
09/17/2003EP1194428B1 Heteroaryl protease inhibitors and diagnostic imaging agents
09/17/2003EP1133471B1 Hydrazine derivatives
09/17/2003EP1023267B1 Pyridyl compounds and pharmaceutical compositions containing them
09/17/2003EP0909184B1 Targeted drug delivery using sulfonamide derivatives
09/17/2003EP0889034B1 Aminopyridine derivatives
09/17/2003EP0754682B9 Aminostilbazole derivative and medicine
09/17/2003CN1443179A Aniline derivatives
09/17/2003CN1443177A Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators
09/17/2003CN1443170A Capsaicin receptor ligands
09/17/2003CN1443169A Chemical process for extraction of 2-hydroxy pyridine derivatives, 2-hydroxyquinoline, and 2-hydroxybenzothiazole
09/17/2003CN1443168A 5-chloro-3-(4-methane sulfonylphenyl)-6-methyl-[2,3'] bipyridine and process for synthesis
09/17/2003CN1443160A N-substituted-1-amino-1,1-dialkyl carboxylic acid derivatives
09/17/2003CN1443154A 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
09/17/2003CN1442412A Preparing method of substituted azoles
09/17/2003CN1442411A Method of continuously preparing substituted azoles
09/17/2003CN1442408A Method of preparing 4-dimethylamino pyridine
09/17/2003CN1121404C Antifungal agent and its preparing process and intermediate
09/17/2003CN1121401C Aminophenol derivates
09/17/2003CN1121393C Substituted aminosalicyclic acid amides with fungicidal effect and intermediate products for production thereof
09/17/2003CN1121390C Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia
09/17/2003CN1121389C Cyanoguanidines as cell proliferation inhibitors
09/17/2003CN1121379C Synthesis and use of retinene derivative having negative hormone and/or antagonist activities
09/17/2003CN1121376C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives and matrix metalloprotease inhibitors
09/16/2003US6620933 Dyes having acid reistance and stability used as colors for silver halide photographic, photosensitive materials, ink jet or thermal printing and as toners in electrophotography, electroluminescence or television displays
09/16/2003US6620849 Bicyclic sulfanimde compounds useful for the treatment of cardiac arrhythmias
09/16/2003US6620827 PPARγ modulators
09/16/2003US6620546 Ionic composition comprising salt having conductivity of greater than 10-5 S.cm-1 between -30 and 150 degrees C; cation is proton, hydronium, hydroxonium, nitrosonium, ammonium or metal cation; anion is carbanion containing fluorine
09/16/2003CA2238875C Tri-aryl ethane derivatives as pde iv inhibitors
09/16/2003CA2085802C 5,6-disubstituted-3-pyridylmethyl ammonium halide compounds useful for the preparation of 5-(substituted methyl) -2,3-pyridinedicarboxylic acids
09/16/2003CA2082629C Novel method for preparing 3-amino-2-chloro-4-alkylpyridines
09/12/2003WO2003074990A2 Artificial receptors, building blocks, and methods
09/12/2003WO2003074495A1 Hppars activators
09/12/2003WO2003074494A1 Halogen-free ionic liquids
09/12/2003WO2003074491A1 O-cyclopropyl-carboxanilides and their use as fungicides
09/12/2003WO2003074487A1 Process for production of optically active compounds
09/12/2003WO2003074476A1 Novel arylamidine derivative or salt thereof
09/12/2003WO2003074475A2 Substituted aryl ketones
09/12/2003WO2003074467A2 Urea derivatives as hiv aspartyl protease inhibitors
09/12/2003WO2003048081A3 Glycinamides as factor xa inhibitors
1 ... 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 ... 633